echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Pondering over the importance of monitoring while comprehensively promoting high price auxiliary base drugs?

    Pondering over the importance of monitoring while comprehensively promoting high price auxiliary base drugs?

    • Last Update: 2019-07-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    After the national health and Health Commission issued the first batch of directory of key monitoring drugs, all localities successively launched local version of the directory based on the national directory combined with the local drug use Recently, Sichuan Province has issued the implementation plan for improving the national basic drug system, some of which are of great concern, that is, the national basic drug varieties should not be included in the key monitoring catalogue of auxiliary drugs in principle, the provincial medical insurance adjusts the priority of national basic drug products, and doctors who do not choose the basic drug will be notified and linked with performance, etc Only the first batch of national key monitoring catalogue has been published, focusing on the nutrition of nerves and heart muscle, immune regulators and vascular dredgers There are many best-selling auxiliary drugs in the new version of national basic drugs, including some high-priced drugs with large dosage In the monitoring catalogue of some provinces and cities that have been issued, the previous generations of products with a large amount of more than 10 yuan and dozens of yuan have been included in the monitoring, while the substitute products with a price of more than 100 yuan are not limited in Sichuan and other major agricultural provinces due to their free use of national base drugs Several years ago, the payment standard of rural cooperative has reached six times of the income of farmers in some areas, which leads to serious overspending In this way, it can only be more tense, which is far from reducing the burden of public drug costs mentioned in the document There are some things to be improved in the national monitoring catalogue, such as putting some products with the lowest price in a category into monitoring It is not effective to distinguish whether the clinical treatment is a treatment or a supplementary drug It is because of the large population base, high incidence rate of some diseases, large dosage of treatment courses, long rehabilitation cycle, and so on However, before the national catalog was fully launched, the local government made its own conclusion, which was a little hasty and abrupt It was also contrary to the national policy of unified implementation of both medical insurance and basic medicine, which no longer gave each region the right to supplement, stressed the will of the state, and was consistent from top to bottom At that time, Guangdong basic drug supplement had become an anti-corruption case due to mixing a large number of high-priced products In a more and more strict and standardized environment, it is worth pondering and paying attention to how a large number of auxiliary drugs enter the base drug and can be released by green light in various places There are many kinds of catalogues, guides and paths waiting for enterprises to show their abilities and invest in a large amount of funds, but only to seek the sustenance to ensure prosperity How can the burden of enterprises not increase? How can they not transfer the wool out of the sheep to the patients and the country? Why is the price of drugs getting lower and lower on the one hand, but on the other hand, the substitute products actually used are becoming more and more expensive? The proportion of medicine is lower and lower, but the cost of medicine is more and more expensive? How to make all the policies and decrees have the same caliber and step by step, so that enterprises will not be lost in all kinds of fatigue, unload thousands of burdens, radiate market vitality, and serve the market well, is particularly crucial in the campaign of medical reform.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.